An early-stage global venture capital firm heavily active in India and Southeast Asia, focusing on tech-enabled SaaS.
About BEENEXT Asia
BEENEXT is a Singapore-headquartered global early-stage fund founded by Teruhide Sato with deep activity across India, Southeast Asia, and increasingly emerging markets globally. The fund’s reputation is built on founder-friendliness, operator-led diligence, and a willingness to write conviction checks early. Stage focus is seed and Series A with checks in the $1M to $5M range, and the thesis is broadly tech-enabled SaaS and digital platforms with healthcare appearing as a sub-theme. AI is not flagged as a primary lens, though many recent BEENEXT investments are AI-adjacent in practice. The right founder for BEENEXT is an Indian or Southeast Asian operator building a B2B SaaS, marketplace, or tech-enabled service product with strong founder-market fit and a credible regional or global expansion narrative; healthcare-specific founders should map cleanly onto SaaS economics or platform dynamics, since the fund is not a healthcare specialist. The wrong founder is a regulated medtech or therapeutics team, a hardware-heavy business, or a hyper-local digital health business without regional ambition. Intro paths run through Sato-san’s operator network including senior figures from Singapore’s Sea, Razer, and Garena ecosystems; through Tokyo and Singapore VC peers such as Beenos, Mistletoe, and Wavemaker Partners; and through Indian funds where BEENEXT regularly co-invests including Sequoia Surge alumni, Blume, and 3one4 Capital. Cold inbound is read by the team and occasionally advances, particularly from technical founders with shipped product. In the pitch, lead with the founder story and the customer evidence; BEENEXT’s diligence weights founder quality heavily and tends to move fast when conviction is reached. Show realistic regional expansion logic, since the fund’s pattern recognition is sharper than most on the cross-border SaaS playbook between India and Southeast Asia. Be specific about your data and AI architecture if relevant, and about regulatory posture in the markets you sell into. Caveats are minor: BEENEXT writes conviction checks but is not a hands-on operator-fund, so founders looking for heavy company-building support should add an angel or specialist alongside. The fund also has a global mandate, which means healthcare partnership depth will not match a dedicated healthcare fund, but the brand and downstream signaling are strong.
Founder reviews
Other portfolio companies
Companies in BEENEXT Asia's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from BEENEXT Asia? Founders only — share your honest experience (anonymous OK, moderated before publishing).